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Background: Increased plasma homocysteine has been
linked to many clinical conditions including atheroscle-
rosis and ischemic stroke. We assessed the genetic and
environmental influences on homocysteine in adult twins
and tested the influence of 3 candidate polymorphisms.
Methods: Homocysteine was analyzed in 1206 healthy
twins, who were genotyped for 3 polymorphisms:
MTHFR 677C>T, MTR 2756A>G, and NNMT (dbSNP:
rs694539). To perform quantitative trait linkage analysis
of theMTHFR locus, the genotyping was supplemented
with 2 genetic markers localized on each site of the
MTHFR locus. The twin data were analyzed using bio-
metric structural equation models as well as a combined
association and linkage analysis in 2 age cohorts.
Results: Age, sex, and MTHFR genotype have a signifi-
cant impact on homocysteine concentrations, whereas
the other genotypes were not associated with homocys-
teine concentrations. The variance in homocysteine
could be solely ascribed to additive genetic and non-
shared environmental factors, with an estimated addi-
tive genetic proportion of total variation at age 18–39
years of 0.63 (95% CI, 0.53–0.71) and at age 40–65 years
of 0.27 (95% CI, 0.10–0.41). The impact of the MTHFR
locus is estimated to explain 53% (95% CI, 0.07–0.67) of
the total phenotypic variation in persons 18–39 years old
and 24% (95% CI, 0.00–0.39) in persons 40–65 years old,
i.e., almost all additive genetic variance.
Conclusions: Homocysteine concentrations have a high
heritability that decreases with age. The MTHFR gene
locus is responsible for almost all the variation attrib-
utable to genetic factors, leaving very little influence of
other genetic variations.
© 2007 American Association for Clinical Chemistry
Homocysteine (Hcy)4 is a sulfur-containing intermediate
of methionine metabolism. Hyperhomocysteinemia has
been linked to many clinical conditions including athero-
sclerosis, ischemic stroke, osteoporosis, cognitive impair-
ment, and death (1–7). The exact pathophysiological
effects of Hcy are incompletely understood, and it still
remains to be proven whether moderate hyperhomocys-
teinemia is a causative factor or a marker of other risk
factors in these diseases.
The underlying causes for mild to moderate hyperho-
mocysteinemia are both genetic and environmental (8 ).
These influences may be mediated by other variables
reflecting genetic and/or environmental effects; thus,
increasing Hcy concentrations are associated with male
sex, smoking, coffee consumption, increasing age, high
blood pressure, unfavorable lipid profile, and high creat-
inine. Variables such as physical activity, moderate alco-
hol consumption, and a good folate or vitamin B-12 status
are associated with lower Hcy concentrations (9 ). Genetic
factors are also thought to directly affect tHcy concentra-
tions (10, 11), although studies have reported very differ-
ent estimates of heritability (12, 13).
Several enzymes are involved in the methionine/ho-
mocysteine metabolic pathway. Cofactors include pyri-
doxine (vitamin B6), vitamin B12, and folate. The 3 key
enzymes involved are methylenetetrahydrofolate reduc-
tase (MTHFR), methionine synthase (MTR), and cystathi-
onine -synthase (CBS). It is well known that a common
polymorphism in the MTHFR gene5 (677CT) has a
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pronounced impact on plasma Hcy concentration. As T
allele dose increases, this functional polymorphism causes
a graded increase in Hcy in the mild-moderate range,
most pronounced in individuals with low dietary folate
consumption (14 ). A common polymorphism in the MTR
gene (2756AG) also seems to influence plasma Hcy,
with the A-allele and the AA genotype associated with
increased Hcy concentration (15 ). No associations of Hcy
concentrations with frequent polymorphisms in CBS have
been found. Other genes have been linked to plasma
Hcy—in a recent study a genomewide scan found a new
candidate gene at chromosome 11q23, the nicotinamide
N-methyltransferase gene (NNMT) as a major determi-
nant of plasma Hcy (16 ). One single-nucleotide polymor-
phism (dbSNP: rs694539) in intron 1 in theNNMT gene was
significantly associated with Hcy concentrations.
We have assessed the genetic and environmental influ-
ences on plasma Hcy as measured in a large population-
based sample of adult twin pairs. Furthermore, we tested
the influence of 3 common polymorphisms in 3 candidate
genes, MTHFR, MTR, and NNMT, that code for enzymes
involved in the synthesis or the metabolism of Hcy, and
estimated their relative contribution to the calculated
heritability.
Materials and Methods
This study is part of a twin study of the metabolic
syndrome and related components (GEMINAKAR) for
which study participants were identified through the
population-based Danish Twin Registry (17 ). The selec-
tion of study participants for inclusion is described in
detail elsewhere (18 ). The regional ethics committee ap-
proved the study and all participants provided informed
consent. In total, 603 adult twin pairs not suffering from
diabetes or cardiovascular diseases [238 dizygotic (DZ),
239 monozygotic (MZ), and 126 opposite-sex pairs (OS)]
participated in the present study. The participants under-
went a thorough clinical physiologic examination and an
oral glucose tolerance test. Plasma for Hcy measurement
was collected in a sodium fluoride (NaF) tube simulta-
neously with the 2-h final glucose measurement. The NaF
tube was centrifuged and plasma was separated within
1 h.
Plasma was kept at80 °C until analysis. Zygosity was
established by use of 9 polymorphic DNA-based micro-
satellite markers with the PE Applied Biosystems Amp-
FISTR Profiler Plus Kit (Perkin-Elmer). Hcy was mea-
sured in plasma samples from 1206 participants by use of
the Imx® Hcy assay and the Imx analyzer (Abbott).
genotyping
Both members of the DZ twin pairs and 1 member from
each MZ twin pair were genotyped. The TaqMan tech-
nology was used to genotype the 3 polymorphisms in
MTHFR (677CT), MTR (2756AG), and NNMT (dbSNP
ID: rs694539). MTHFR and MTR genotyping procedures
were performed as previously described (19 ). NNMT
genotyping was performed with a TaqMan single-nucle-
otide polymorphism genotyping assay (ID: C_2134722_10).
To perform quantitative trait linkage analysis of the
MTHFR locus, the genotyping was supplemented with
the genetic markers D1S2740 and D1S2667 localized on
each site of the locus. These markers have an observed
heterozygosity of 0.62 and 0.83. The sense primers were
labeled with 6-FAM. PCR products were resolved on the
MegaBACE 1000 and analyzed with Fragment Profiler
software (Amersham Biosciences).
statistical analysis
The statistical program package Stata (StataCorp, Stata
Statistical Software: Release 8.0) was used for the statisti-
cal calculation. The distribution of genotypes and the
presence of Hardy-Weinberg equilibriumwere tested by a
2 test. Because the plasma concentrations of Hcy had a
skewed distribution, all values were transformed by nat-
ural logarithm before analysis. We used ANOVA to
compare mean Hcy according to age, sex, body mass
index (BMI), smoking, fasting glucose, time of year, and
MTHFR, NNMT, and MTR genotype.
estimation of intrapair correlations
In humans 2 types of twinning occur: MZ twins share all
their segregating genes and DZ twins, like ordinary
siblings, share, on average, 50% of their genes. In the
classical twin study, MZ and DZ intraclass correlations
for a trait are compared. A higher correlation in MZ twins
indicates that genetic factors contribute to the variation.
The intrapair correlations for the MZ and the same- and
opposite-sex DZ twin pairs were pooled and estimated
with Mx software (20 ). The covariates sex and age were
included.
estimation of heritability
To estimate heritability of Hcy, we used data from intact,
same-sex, and opposite-sex twin pairs. The twin data
were analyzed using biometric structural equation mod-
els (20 ). It was assumed that the total variance (V) in a
scale could be decomposed as:
V  A  D  C  E,
where A refers to the variance contribution of additive
genetic effects, D refers to the variance contribution of
genetic effects due to dominance (intralocus interaction),
C refers to the variance contribution of shared environ-
mental effects (i.e., environmental factors that are shared
by twins reared together and thus a source of their
similarity), and E refers to the variance contribution of
nonshared environmental effects (i.e., environmental fac-
tors that are not shared by twins reared together, which in
(NADPH); MTR, 5-methyltetrahydrofolate-homocysteine methyltransferase
reductase; NNMT, nicotinamide N-methyltransferase; and CBS, cystathionine-
beta-synthase.
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the analysis are considered as a source of random
variation).
Variance components are estimated by the maximum
likelihood method using the Mx software (20 ). An ACE
sex limitation model was fitted to evaluate whether dif-
ferent sets of genes influence Hcy concentration expres-
sion in males and females. Afterward the following mod-
els were fitted: ACE, ADE, AE, DE, CE, and E. Age and
sex were included as covariates in the variance compo-
nents models. The best-fitting model was chosen in accor-
dance with the lowest Akaiki information criterion (AIC)
(2  loglikelihood  2  df) (21 ). Thereby both the good-
ness of fit and the simplicity of the model were taken into
account in model selection.
To account for the possibility that different genetic
variations may influence plasma Hcy at different ages, the
analyses were done in 2 age cohorts, young twins (18–39
years) and middle-aged twins (40–65 years). These age
cohorts were selected because they each contained ap-
proximately half of the study population.
linkage analysis
The linkage analysis, the association analysis, and the
combined analyses were performed as described by Beek-
man et al. (22 ). The software package Merlin 1.0.1 was
used to estimate the distribution of the identity-by-de-
scent probabilities at the MTHFR locus (23 ).
The linkage model for the natural logarithm of the Hcy
concentration is:
yij    1  ageij  2  sexij  eij,
where yij is the observed log-Hcy concentration for twin j
in the i-th twin pair,  denotes the grand mean, 1 denotes
the regression coefficient for age, 2 denotes the deviation
of females, and eij denotes a residual that is not explained
by age and sex. The variance of eij is decomposed into A,
E, and additive genetic variance due to a quantitative trait
locus (QTL) in the vicinity of the marker. No other
variance components were included, because the previ-
ous twin analysis found the best-fitting model to be the
AE model. We used a weighted likelihood approach to
obtain maximum advantage of the full distribution of the
identity-by-descent probabilities.
association analysis
The association model for the natural logarithm of the
observed Hcy concentrations as a function of the MTHFR
polymorphism is
yij    1  ageij  2  sexij  ab  Abi
 db  Dbi  aw  Awij  dw  Dwij  eij,
where yij is the observed score for twin j in the i-th twin
pair and , 1, and 2 denote as above. Abi is the derived
coefficient for the additive genetic effect of the MTHFR
polymorphism between twin pairs for the i-th twin pair;
Awij denotes the coefficient as derived for the additive
genetic effects of theMTHFR polymorphism within twins
for twin j from the i-th family; Dbi is the coefficient for the
dominant genetic effect of the MTHFR polymorphism
between twin pairs for the i-th twin pair; Dwij denotes the
coefficient for the dominant genetic effects of the MTHFR
polymorphism within twin pairs for twin j from the i-th
twin pair; ab and aw are the estimated additive effects
between and within twin pairs; db and dw are the esti-
mated dominance effects between and within families;
and eij denotes a residual that is not explained by the age,
sex, or allelic effects of the MTHFR polymorphism. The
variance of eij is decomposed into A and E components.
Population stratification was tested by constraining ge-
netic effects within and between twin pairs (i.e., aw  ab
and dw  db), and the presence of nonadditive allelic
effects at theMTHFR locus was tested by constraining the
dominance coefficients to zero (dw  db  0) (22, 24, 25).
combined association and linkage analysis
The association model that provided the most parsimoni-
ous fit to the data (lowest AIC) was taken as a starting
point for the combined association and linkage analysis.
In the combined model, the variance in the natural
logarithm of the Hcy concentrations that was not ac-
counted for by age, sex, and the MTHFR polymorphism
(eij) was decomposed into A, E, and Q components and
thus was tested for the MTHFR polymorphism whether
linkage with the log-Hcy concentration was still present
when modeled simultaneously with association of the
MTHFR polymorphism (24, 25). Again we used a
weighted likelihood approach to account for the full
distribution of identity-by-descent probabilities.
Because the correlations between twins 1 and 2 in some
of the twin pairs could have been outliers (a scatter plot of
the log-Hcy concentration between twin 1 and 2 is shown
in Fig. 1), the estimation of heritability, association, and
linkage analysis were repeated after exclusion of the pairs
with the highest difference, a total of 2%.
Results
Sample characteristics and the Hcy distribution are shown
in Tables 1 and 2. The covariates age, sex, and MTHFR
genotype had a significant impact on tHcy (P 0.03),
whereas BMI, season (summer or winter), smoking, fast-
ing blood glucose, and genotypes for NNMT and MTR
(P 0.74) were without a significant impact. Mean (SD) is
shown in Table 2 divided in groups according to age, sex,
and MTHFR genotype.
distribution of genotypes
The genotype distributions (Table 1) are compatible with
the Hardy-Weinberg equilibrium for the population as a
whole [P  0.99 (MTHFR), P  0.37 (MTR), and P  0.19
(NNMT)], as well as for females [P  0.98 (MTHFR), P 
0.89 (MTR), and P  0.58 (NNMT)]. For males the distri-
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bution was in Hardy-Weinberg equilibrium for MTHFR
and MTR (P  0.97 and P  0.15). The distribution for
NNMT, however, deviated significantly from Hardy-
Weinberg equilibrium (P  0.006) because of fewer than
expected heterozygotes.
estimation of heritability
Both age groups exhibited significantly higher intrapair
correlations for MZ than DZ twin pairs (youngest group,
P  0.002; oldest group, P  0.05). The excess similarity
for MZ compared to DZ pairs indicates a significant
genetic influence on log-Hcy concentration.
The sex limitation ACE model showed no sex differ-
ences in genetic relationships for the natural logarithm of
Hcy concentration (P  0.88 in the youngest group, P 
0.39 in the oldest) (results not shown). Therefore, the
opposite-sexed twin pairs were included together with
the same-sex DZ twin pairs in all subsequent analyses. In
both age groups we found that the best-fitting model in
the twin analysis (lowest AIC) was the AE model that
included sex and age as covariates, a finding indicating
that the proportion of variance in Hcy concentration
for given sex and age is solely due to additive genetic
factors (A) and nonshared environmental factors (E) (Ta-
bles 3 and 4).
linkage analysis
In the youngest twin group the analysis showed a signif-
icant QTL effect of theMTHFR locus (P  0.04) compared
to an AE model, but for the oldest group this effect was
insignificant (P  0.57). The QTL effect was thus esti-
mated to account for a considerable proportion of the
phenotypic variance and most of the additive genetic
variance.
association analysis
In both age groups, association had significant effect on
log Hcy concentration (P 0.001), and there was no
evidence for the presence of population stratification (P
0.11 and P  0.36 in the 2 age groups). We could not
exclude from the model a genetic dominant effect associ-
0
1
2
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Tw
in
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0 1 2 3 4
Twin 1
18−39 year 40−65 year Outliers
Fig. 1. A scatter plot of the log-Hcy concentration in twin 1 and
2 in a twin pair.
The 2% most deviating pairs are deleted in the confirmatory statistical
analyses and are marked with an X.
Table 1. Sample characteristics.a
Males (n  592) Females (n  614)
Age, mean (range) 38.1 (18–63) 38.2 (18–67)
Body mass index,
mean (range)
24.8 (17.7–40.4) 24.0 (16.4–43.7)
Fasting glucose 4.7 (2.7–9.3) 4.9 (2.8–13.0)
Summer, % 38.1 39.0
Smoking, n (%) 198 (33.4) 200 (32.5)
No. of MZ 234 244
Estrogen use, n (%) 124 (20.1)
Systolic BP, mmHg (SD) 120.6 (13.5) 114.0 (14.5)
Diastolic BP, mmHg (SD) 70.9 (10.3) 68.2 (10.4)
Total cholesterol,
mmol/L (SD)
5.5 (1.2) 5.5 (1.2)
Genotype distribution
MTHFR CC CT TT CC CT TT
(n  1136) 269 235 51 288 242 51
MTR AA AG GG AA AG GG
(n  1126) 376 153 23 377 177 20
NNMT GG GA AA GG GA AA
(n  1095) 380 134 25 360 178 18
a Summer: samples drawn between May 1 and October 31.
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ated with the MTHFR locus (P 0.001 in the youngest),
although it showed only borderline significance in the
oldest age group (P  0.03).
combined linkage and association
We modeled the QTL effect together with the best-fitting
association model (no population stratification). The
youngest age group showed significant QTL in the pres-
ence of association (P  0.03). The effect of the QTL
situated in the MTHFR locus was estimated to explain
53% of the total variation in study participants in the
18–39 year age group, a result indicating that MTHFR
variation apart from 677TC is significant. In the oldest
age group an estimated 24% of the total variance was due
to the QTL, a value that did not differ significantly from
zero (P  0.54).
retesting after exclusion of outliers
The statistical analyses were repeated after exclusion of
the samples suspected to be outliers (Table 5). The esti-
Table 2. Distribution of total plasma Hcy.a
Age
<30 years >30 years
Males
Hcy mol/L, mean (SD) 8.06 (3.80), n  172 8.70 (3.39), n  419
MTHFR genotype CC CT TT CC CT TT
Hcy mol/L, mean (SD) 6.98 (1.80),
n  79
7.98 (2.58),
n  59
14.98 (8.59),
n  14
8.27 (2.21),
n  189
8.67 (3.31),
n  176
11.45 (6.64),
n  37
Females
Hcy mol/L, mean (SD) 6.87 (2.37), n  169 7.52 (2.93) n  446
MTHFR genotype CC CT TT CC CT TT
Hcy mol/L, mean (SD) 6.53 (2.26),
n  71
6.68 (1.73),
n  75
9.46 (4.02),
n  16
6.90 (1.96),
n  217
7.88 (2.77),
n  165
10.16 (5.56),
n  35
a Genotype is missing in 37 males and 36 females due to lack of DNA material.
Table 3. Fit statistics of nested models in young (18–39 years) Danish twins.
qa 2LL AIC vs df 2 P Remarks
Model
0 Saturated 12 321.223 345.223 rmz  0.64 (0.53;0.72)
rdz  0.30 (0.16;0.42)
1 ACE 6 327.075 339.075 1 vs 0 6 5.85 0.44
2 AE 5 327.075 337.075 2 vs 1 1 0.00 1.00 a2  0.63 (0.53;0.71)
e2  0.37 (0.29;0.47)
3 CE 5 344.487 354.487 3 vs 1 1 17.41 0.001
4 E 4 413.432 421.432 4 vs 2 1 86.36 0.001
5 ADE 6 327.016 339.016 5 vs 0 6 5.79 0.45
6 DE 5 331.110 341.110 6 vs 5 1 4.09 0.04
Linkage  sex, age
7 AEQ 6 322.983 334.983 5 vs 7 1 4.09 0.04 a2  0.15 (0.00;0.63)
e2  0.35 (0.27;0.44)
q2  0.50 (0.02;0.72)
Association  sex, age
8 AE  ab  aw  db  dw 9 263.057 281.057 5 vs 8 4 64.02 0.001
9 AE  (ab  aw)  (db  dw) 7 267.513 281.513 9 vs 8 2 4.46 0.11 a
2  0.57 (0.45;0.66)
e2  0.43 (0.33;0.55)
10 AE  (ab  aw)
 (db  dw  0)
6 279.980 291.980 10 vs 9 1 12.47 0.001
Linkage in the presence of
association  sex, age
11 AEQ  (ab  aw)
 (db  dw)
8 262.516 278.516 9 vs 11 1 5.00 0.03 a2  0.06 (0.00;0.51)
e2  0.41 (0.32;0.52)
q2  0.53 (0.07;0.67)
a q, No. of estimated parameters; 2LL, 2  log likelihood; AIC, 2LL  2  q; vs, model comparison; df, no. of degrees of freedom; 2, difference in 2LL; P,
probability of type 1 error.
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mates of A and E are in the same order as before
exclusion; however, the significant QTL effect of the
MTHFR locus disappears.
Discussion
Plasma Hcy concentrations showed pronounced differ-
ences according to age, sex, and MTHFR genotype (Table
2). This finding is in accordance with previous studies
identifying effects of lifestyle and specific genetic factors
on Hcy concentrations (26, 27). Although smoking, BMI,
season, fasting blood glucose, and MTR and NNMT
genotype, among other factors, have previously been
shown to influence Hcy concentrations, the impact of
these specific variables was not significant in our study.
This study confirms that the MTHFR 677CT polymor-
phism has a marked effect on Hcy plasma concentrations.
The magnitude of this effect is so great that it calls into
question the use of a single common reference interval for
plasma Hcy concentrations.
The distribution of alleles in NNMT is in Hardy-
Weinberg equilibrium in the population as a whole and in
females, but not in males. Deviation from Hardy-Wein-
berg equilibrium could be due to genotyping error,
chance, failure of assumptions underlying Hardy-Wein-
Table 4. Fit statistics of nested models in middle-aged (40–65 years) Danish twins.
qa 2LL AIC vs df 2 P Remarks
Model
0 Saturated 12 303.315 327.315 rmz  0.28 (0.09;0.44)
rdz  0.12 (0.05;0.27)
1 ACE 6 317.049 329.049 1 vs 0 6 13.73 0.03
2 AE 5 317.049 327.049 2 vs 1 1 0.00 1.00 a2  0.27 (0.10;0.41)
e2  0.73 (0.59;0.90)
3 CE 5 318.705 328.705 3 vs 1 1 1.66 0.20
4 E 4 326.950 334.950 4 vs 2 1 9.90 0.002
5 ADE 6 316.989 328.989 5 vs 0 6 13.67 0.03
6 DE 5 317.279 327.279 6 vs 5 1 0.29 0.59
Linkage  sex, age
7 AEQ 6 316.724 328.724 5 vs 7 1 0.33 0.57 a2  0.04 (0.00;0.41)
e2  0.74 (0.59;0.90)
q2  0.23 (0.00;0.41)
Association  sex, age
8 AE  ab  aw 
db  dw
9 296.879 314.879 5 vs 8 4 20.17 0.001
9 AE  (ab  aw)
 (db  dw)
7 297.705 311.705 9 vs 8 2 0.83 0.36 a2  0.25 (0.08;0.40)
e2  0.75 (0.60;0.92)
10 AE  (ab  aw)
 (db  dw  0)
6 302.162 314.162 10 vs 9 1 4.46 0.03
Linkage in the presence of
association  sex, age
11 AEQ  (ab  aw)
 (db  dw)
8 297.137 313.137 9 vs 11 1 0.57 0.54 a2  0.00 (0.00;0.39)
e2  0.76 (0.61;0.91)
q2  0.24 (0.00;0.39)
a q, No. of estimated parameters; 2LL, 2  loglikelihood; AIC, 2LL  2  q (Akaiki’s information criterion); vs, model comparison; df, no. of degrees of freedom;
2, difference in 2LL; P, probability of type 1 error.
Table 5. Fit statistics of nested models after exclusion of outliers.
Young twins (18–39 years)
Model A2 e2 q2 P (QTL  0)
AE 0.67 	0.58;0.74
 0.33 	0.26;0.42

AEQ 0.44 	0.00;0.74
 0.33 	0.26;0.41
 0.23 	0.00;0.70
 0.48
AEQ  association 0.25 	0.00;0.68
 0.38 	0.30;0.48
 0.37 	0.00;0.68
 0.18
Middle aged twins (40–65 years)
AE 0.48 	0.35;0.60
 0.52 	0.40;0.66

AEQ 0.48 	0.01;0.60
 0.52 	0.40;0.66
 0.00 	0.00;0.44
 1.00
AEQ  association 0.46 	0.00;0.58
 0.54 	0.42;0.68
 0.00 	0.00;0.46
 1.00
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berg expectations, or selection against certain genotypes.
In the absence of an obvious reason for this finding, we
interpret it as a chance finding.
With heritability defined as the proportion of the total
variation in the trait that is due to genetic factors, our twin
analyses show that Hcy concentrations were highly heri-
table, with a heritability of 63%, in the twins in the
younger age group (18–39 years), but heritability de-
creased to 27% in the older twin group (40–65 years).
When the component attributable to the MTHFR gene
locus was included in the analyses, this component ac-
counted for almost all of the heritability. This finding was
significant in the younger age group but not completely
significant in the older group, as indicated by inclusion of
zero in the CI. One possible explanation for the drop in
heritability with age could be that the total variance due
to environmental factors increases with age and thereby
decreases the heritability. Hcy concentrations increase
with age, probably because of an age-dependent decrease
in kidney function. This increase could decrease the
relative importance of genetic influences.
Several correlations between the twin pairs (Fig. 1)
may be outliers. Reliable statistical identification of outli-
ers in a data set remains a challenge, and there are no clear
recommendations as how to treat outliers. After exclusion
of the 2% most deviating twin correlations, estimates of A
and E were almost unchanged, but the QTL effect of the
MTHFR locus was no longer significant, indicating that
the results from the QTL analysis were driven by the
outliers. Another explanation is that the combined asso-
ciation and linkage analysis, described by Beekman et al.
(22 ) and used in this study, lacks power to detect loci
affecting quantitative variation unless the QTL exerts a
large effect or the number of study participants is very
large. Given that our study had 180 sibling pairs in each
group, it is not surprising that the estimates of Q, or
residual Q after allowing for association, have wide CIs
(Tables 3 and 4).
The estimated heritability is in accordance with most
published studies (13 ), although a previous twin study
failed to detect any heritability (12 ), most likely due to
small sample size (60 twin pairs). However, because
heritability is a population-specific measurement reflect-
ing the relative influences of genetic and environmental
variation in the particular population, such findings could
also be due to massive variation in environmental influ-
ence on Hcy concentrations in the selected population.
For example, very large differences in folate consumption
could probably obscure any genetic influence.
The finding in several previous studies that mild-to-
moderate hyperhomocysteinemia is associated with cog-
nitive dysfunction, cardiovascular diseases, and stroke
(1–7)makes it tempting to believe that decreasing Hcy by
B-vitamin supplementation may have a protective effect
that arrests or slows the disease processes. The results
from the Hcy-lowering trials have been conflicting, how-
ever. Two recently completed clinical trials, the Vitamin
Intervention for Stroke Prevention and the Vitamin and
Thrombosis trials, found no significant effects of Hcy-
lowering therapy on vascular outcomes in patients with
prior stroke (28 ) or venous thromboembolism (29 ). In a
subgroup of 2155 patients from the Vitamin Intervention
for Stroke Prevention trial, however, an efficacy analysis
derived after exclusion of participants with baseline B12
concentrations below the 25th or above the 95th percentile
and/or glomerular filtration rates below the 10th percen-
tile showed a 21% reduction in the risk of vascular events
(30 ). Results from the ongoing Hcy-lowering trials must
be analyzed before recommendations can be made on the
use of B-vitamins for prevention of vascular disease.
Whether increased Hcy mediates or is merely an indi-
cator of metabolic abnormalities that lead to cardiovascu-
lar disease is uncertain. The finding that Hcy has a
heritability of 27%–65% and that this genetic component
is mostly attributable to theMTHFR gene locus highlights
a possible association between this locus and disease
progression. Several studies have looked into this possible
association, however, and a recent metaanalysis did not
provide evidence to support an association between the
MTHFR 677CT polymorphism and coronary heart dis-
ease (31 ). The obvious conclusion is therefore that the
disease risk associated with mild to moderate hyperho-
mocysteinemia is not an inherited risk. It is much more
likely that increased Hcy is not a causal mechanism but a
marker for an environmental disease risk such as inade-
quate vitamin supplementation or simply a phenomenon
associated with existing disease.
To perform a combined association and linkage anal-
ysis to determine to what extent the polymorphisms in the
MTHFR locus account for the observed heritability in Hcy
plasma concentrations, we supplemented the genetic
analysis with 2 genetic markers located on each site of the
MTHFR locus, a procedure that enabled us to differentiate
identity-by-descent from identity-by-state covariances.
Combined association and linkage analysis is a powerful
tool for pinpointing functional quantitative traits (QTLs)
responsible for regions of significant linkage identified in
genome-wide scans. The analysis revealed that the asso-
ciation of the MTHFR gene locus to Hcy plasma concen-
trations completely explained the linkage in the younger
twin group and partly in the middle-aged twin group.
The analysis also revealed that MTHFR genetic variation
influences Hcy apart from 677CT. Several genome-wide
linkage scans have been conducted in an effort to localize
genes influencing variation in plasma Hcy concentrations.
One study identified an NNMT gene locus (16 ), which
was tested in our study and shown to be without signif-
icant influence. A recent linkage study could not confirm
this linkage result, but identified 3 other regions that
showed weak to suggestive linkage to Hcy concentrations
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(13 ). This finding is not surprising, because random
genomic screening of a complex trait does not have high
power, and false-positive findings are common. We show
that the MTHFR locus does account for nearly all of the
heritability components in the younger twin group, thus
making it very unlikely that a genomic screening would
have the power to identify new loci involved in the Hcy
concentration, because the impact of these regions must
be very small.
In conclusion, we demonstrated that Hcy concentrations
have a high heritability that decreases with age. The
MTHFR gene locus is responsible for almost all the
variation attributable to genetic factors, leaving only mi-
nor influence to other genetic variations.
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